EP2359809
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.12.2006EP published:
14.8.2019EP application number:
10175382.0
EPO information:
European Patent Register
Max expiry date:
19.12.2026
Title:
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
Timeline
Today
20.12.2006EP application
14.8.2019EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Petersen, HolgerAddress:
Eimeldingen, DE
Name:
Ahlheim, MarkusAddress:
Staufen, DE
Priority
Number:
0526247Date:
22.12.2005Country:
GB
Number:
06119086Date:
17.8.2006Country:
EP
Classification
Categories:
A61K 9/16, A61K 38/31, A61K 49/00